Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15981097)

  • 1. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
    Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
    J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma.
    Facoetti A; Ranza E; Nano R
    Anticancer Res; 2008; 28(1A):15-9. PubMed ID: 18383819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.
    Ellison DW; Steart PV; Gatter KC; Weller RO
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):352-61. PubMed ID: 7494604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 protein overexpression in astrocytic neoplasms.
    Cho MY; Jung SH; Kim TS
    Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival.
    Vlodavsky E; Soustiel JF
    J Neurooncol; 2007 Jan; 81(1):1-7. PubMed ID: 16868661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axin induces cell death and reduces cell proliferation in astrocytoma by activating the p53 pathway.
    Zhang LY; Ye J; Zhang F; Li FF; Li H; Gu Y; Liu F; Chen GS; Li Q
    Int J Oncol; 2009 Jul; 35(1):25-32. PubMed ID: 19513548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
    Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of cyclin A in astrocytic tumours.
    Chakrabarty A; Bridges LR
    Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.
    Nakamura M; Konishi N; Tsunoda S; Hiasa Y; Tsuzuki T; Inui T; Sakaki T
    Cancer; 1997 Jul; 80(2):242-9. PubMed ID: 9217037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent astrocytic tumours--a study of p53 immunoreactivity and malignant progression.
    Sarkar C; Ralte AM; Sharma MC; Mehta VS
    Br J Neurosurg; 2002 Aug; 16(4):335-42. PubMed ID: 12389885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL10 in low-grade astrocytomas and glioblastoma multiforme: A tissue microarray-based comparison.
    Sharma I; Siraj F; Sharma KC; Singh A
    J Cancer Res Ther; 2016; 12(2):793-7. PubMed ID: 27461653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of apoptosis and its related protein in astrocytic tumors.
    Takekawa Y; Sawada T; Sakurai I
    Brain Tumor Pathol; 1999; 16(1):11-6. PubMed ID: 10532418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative index in astrocytic tumours.
    Rathi KR; Radotra BD; Khosla VK
    Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of spontaneous apoptosis in gastric cancer: relation to proliferative index, p53 expression, CD 34 expression and histopathological features.
    Jesionek-Kupnicka D; Tenderenda M; Rutkowski P
    J Exp Clin Cancer Res; 2002 Sep; 21(3):371-5. PubMed ID: 12385580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
    Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
    J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.
    Ellison DW; Steart PV; Bateman AC; Pickering RM; Palmer JD; Weller RO
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):413-9. PubMed ID: 7561922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of apoptotic pathways and c.Jun/JNK expression in malignant gliomas.
    Schiffer D; Ferracini R; Cavalla P
    Anticancer Res; 2001; 21(4A):2531-5. PubMed ID: 11724318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
    Suren D; Isiksacan Ozen O
    J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.